Patents by Inventor Graça Raposo

Graça Raposo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SKIN WHITENING PEPTIDE AGENTS
    Publication number: 20200281838
    Abstract: The present invention provides new peptides useful as skin whitening agents and their uses in cosmetic or therapeutic applications.
    Type: Application
    Filed: March 26, 2020
    Publication date: September 10, 2020
    Inventors: GRACA RAPOSO, CECILE CAMPAGNE, CEDRIC DELEVOYE
  • Skin whitening peptide agents
    Patent number: 10603265
    Abstract: The present invention provides new peptides useful as skin whitening agents and their uses in cosmetic or therapeutic applications.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: March 31, 2020
    Assignees: INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Graca Raposo, Cecile Campagne, Cedric Delevoye
  • SKIN WHITENING PEPTIDE AGENTS
    Publication number: 20170246098
    Abstract: The present invention provides new peptides useful as skin whitening agents and their uses in cosmetic or therapeutic applications.
    Type: Application
    Filed: August 31, 2015
    Publication date: August 31, 2017
    Inventors: GRACA RAPOSO, CECILE CAMPAGNE, CEDRIC DELEVOYE
  • Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis
    Patent number: 8669238
    Abstract: The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in particular Kif13A, or of the interaction between a sub-unit of AP-1 adaptor complex and said kinesin, as well as the use of same to manufacture a drug intended for the treatment of pigmentary disorders and as a depigmentation agent.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: March 11, 2014
    Assignees: Institut Curie, Centre National de la Recherche Scientifique (CNRS)
    Inventors: Graca Raposo, Cédric Delevoye, Danièle Tenza, Ilse Hurbain
  • USE OF KIF13A AND AP-1 INHIBITORS FOR INHIBITING MELANOGENESIS
    Publication number: 20120321575
    Abstract: The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in particular Kif13A, or of the interaction between a sub-unit of AP-1 adaptor complex and said kinesin, as well as the use of same to manufacture a drug intended for the treatment of pigmentary disorders and as a depigmentation agent.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 20, 2012
    Applicants: INSTITUT CURIE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Graca Raposo, Cédric Delevoye, Danièle Tenza, Ilse Hurbain
  • Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis
    Publication number: 20110038853
    Abstract: The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in particular Kif13A, or of the interaction between a sub-unit of AP-1 adaptor complex and said kinesin, as well as the use of same to manufacture a drug intended for the treatment of pigmentary disorders and as a depigmentation agent.
    Type: Application
    Filed: April 21, 2009
    Publication date: February 17, 2011
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT CURIE
    Inventors: Graca Raposo, Cédric Delevoye, Danièle Tenza, Ilse Hurbain
  • Sensitization process for antigen-presenting cells and means for implementing the process
    Patent number: 7625573
    Abstract: The object of the invention is a novel sensitization process for antigen-presenting cells, novel means for implementing the process and novel membrane vesicles possessing immunogenic potency. The invention relates in particular to texosomes (vesicles derived from tumor cells) and dexosomes (vesicles derived from dendritic cells loaded or not with antigens), and their use for the vectorization and presentation of antigens in vitro or in vivo as well as in methods or compositions for the treatment of cancers and infectious, parasitic or autoimmune diseases in particular.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: December 1, 2009
    Assignees: Cetre National de la Recherche Scientifique, Institute Curie, Institute Gustave Roussy
    Inventors: Laurence Zitvogel, Graça Raposo, Armelle Regnault, Sebastian Amigorena
  • Compositions and methods using lactadherin or variants thereof
    Publication number: 20040241179
    Abstract: The present invention relates to novel methods and composition that can be used in the biological, experimental and medical areas. More particularly, the invention relates to compositions and methods using lactadherin or variants thereof, or a corresponding nucleic acid, for regulating (i.e., inducing, inhibiting, stimulating, etc.) or monitoring an immune response, more specifically a CTL response, as well as for the delivery of molecules to dendritic cells, in vitro, ex vivo or in vivo.
    Type: Application
    Filed: June 21, 2004
    Publication date: December 2, 2004
    Inventors: Graca Raposo, Clotilde Thery, Sebastian Amigorena
  • Sensitization process for antigen-presenting cells and means for implementing the process
    Publication number: 20040028692
    Abstract: The object of the invention is a novel sensitization process for antigen-presenting cells, novel means for implementing the process and novel membrane vesicles possessing immunogenic potency. The invention relates in particular to texosomes (vesicles derived from tumor cells) and dexosomes (vesicles derived from dendritic cells loaded or not with antigens), and their use for the vectorization and presentation of antigens in vitro or in vivo as well as in methods or compositions for the treatment of cancers and infectious, parasitic or autoimmune diseases in particular.
    Type: Application
    Filed: July 2, 2003
    Publication date: February 12, 2004
    Inventors: Laurence Zitvogel, Graca Raposo, Armelle Regnault, Sebastian Amigorena
  • Sensitization process for antigen-presenting cells and means for implementing the process
    Patent number: 6685911
    Abstract: The object of the invention is a novel sensitization process for antigen-presenting cells, novel means for implementing the process and novel membrane vesicles possessing immunogenic potency. The invention relates in particular to texosomes (vesicles derived from tumor cells) and dexosomes (vesicles derived from dendritic cells loaded or not with antigens), and their use for the vectorization and presentation of antigens in vitro or in vivo as well as in methods or compositions for the treatment of cancers and infectious, parasitic or autoimmune diseases in particular.
    Type: Grant
    Filed: March 15, 1999
    Date of Patent: February 3, 2004
    Assignees: Institut National de la Sante et de la Recherche Medicale, Institut Gustave Roussy, Centre National de la Recherche Scientifique, Institut Curie
    Inventors: Laurence Zitvogel, Graça Raposo, Armelle Regnault, Sebastian Amigorena